1-7 of 7
Veronique Gelsi-Boyer
Close
Sort by
Journal Articles

Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation

Marine Duranjou, Cécile Castoldi, Anne Sophie Alary, Yosr Hicheri, Colombe Saillard, Camille Rouzaud, Aude Charbonnier, Bilal Mohty, Evelyne D'Incan, Jerome Rey, Marie Anne Hospital, Raynier Devillier, Norbert Vey, Véronique Gelsi-Boyer, Anne-Catherine Lhoumeau, Anne Murati, Florence Golesi, Marie Joelle Mozziconacci, Antoine Ittel, Sylvain Garciaz
Journal: Blood
Blood (2023) 142 (Supplement 1): 6483.
https://doi.org/10.1182/blood-2023-186086
Published: 2023
Journal Articles

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Alexandre Fagnan, Frederik Otzen Bagger, Maria-Riera Piqué-Borràs, Cathy Ignacimouttou, Alexis Caulier, Cécile K. Lopez, Elie Robert, Benjamin Uzan, Véronique Gelsi-Boyer, Zakia Aid, Cécile Thirant, Ute Moll, Samantha Tauchmann, Amina Kurtovic-Kozaric, Jaroslaw Maciejewski, Christine Dierks, Orietta Spinelli, Silvia Salmoiraghi, Thomas Pabst, Kazuya Shimoda, Virginie Deleuze, Hélène Lapillonne, Connor Sweeney, Véronique De Mas, Betty Leite, Zahra Kadri, Sébastien Malinge, Stéphane de Botton, Jean-Baptiste Micol, Benjamin Kile, Catherine L. Carmichael, Ilaria Iacobucci, Charles G. Mullighan, Martin Carroll, Peter Valent, Olivier A. Bernard, Eric Delabesse, Paresh Vyas, Daniel Birnbaum, Eduardo Anguita, Loïc Garçon, Eric Soler, Juerg Schwaller, Thomas Mercher
Journal: Blood
Blood (2020) 136 (6): 698–714.
https://doi.org/10.1182/blood.2019003062
Published: 2020
Includes: Supplemental data
Journal Articles

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

Frederik Damm, Virginie Chesnais, Yasunobu Nagata, Kenichi Yoshida, Laurianne Scourzic, Yusuke Okuno, Raphael Itzykson, Masashi Sanada, Yuichi Shiraishi, Véronique Gelsi-Boyer, Aline Renneville, Satoru Miyano, Hiraku Mori, Lee-Yung Shih, Sophie Park, François Dreyfus, Agnes Guerci-Bresler, Eric Solary, Christian Rose, Stéphane Cheze, Thomas Prébet, Norbert Vey, Marion Legentil, Yannis Duffourd, Stéphane de Botton, Claude Preudhomme, Daniel Birnbaum, Olivier A. Bernard, Seishi Ogawa, Michaela Fontenay, Olivier Kosmider
Journal: Blood
Blood (2013) 122 (18): 3169–3177.
https://doi.org/10.1182/blood-2012-11-469619
Published: 2013
Includes: Supplemental data
Journal Articles

BCOR Mutations Represent an Independent Factor of Poor Prognosis in Myelodysplastic Syndromes

Frederik Damm, Chesnais Virginie, Laurianne Scourzic, Veronique Gelsi-Boyer, Aline Renneville, Francois Dreyfus, Sophie Park, Odile Beyne-Rauzy, Borhane Slama, Agnès Guerci-Bresler, MD, Bruno Quesnel, Eric Solary, Aline schmidt-Tanguy, Stephane Cheze, Christian Rose, Thomas Prebet, Stephane de Botton, Norbert Vey, Claude Preudhomme, Daniel Birnbaum, Olivier A. Bernard, PhD, Michaela Fontenay, MD, PhD, Olivier Kosmider, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1697.
https://doi.org/10.1182/blood.V120.21.1697.1697
Published: 2012
Journal Articles

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Frederik Damm, Olivier Kosmider, Véronique Gelsi-Boyer, Aline Renneville, Nadine Carbuccia, Claire Hidalgo-Curtis, Véronique Della Valle, Lucile Couronné, Laurianne Scourzic, Virginie Chesnais, Agnes Guerci-Bresler, Bohrane Slama, Odile Beyne-Rauzy, Aline Schmidt-Tanguy, Aspasia Stamatoullas-Bastard, François Dreyfus, Thomas Prébet, Stéphane de Botton, Norbert Vey, Michael A. Morgan, Nicholas C. P. Cross, Claude Preudhomme, Daniel Birnbaum, Olivier A. Bernard, Michaela Fontenay
Journal: Blood
Blood (2012) 119 (14): 3211–3218.
https://doi.org/10.1182/blood-2011-12-400994
Published: 2012
Includes: Supplemental data
Journal Articles

Presence of TET2 Mutation Predicts A Higher Response Rate to Azacitidine In MDS and AML Post MDS

Raphael Itzykson, Olivier Kosmider, Thomas Cluzeau, Veronique De Mas, Francois Dreyfus, Bruno Quesnel, MD, PhD, Odile Beyne-Rauzy, Norbert Vey, MD, Veronique Gelsi-Boyer, Sophie Raynaud, Claude Preudhomme, Lionel Ades, MD, Pierre Fenaux, MD, PhD, Michaela Fontenay
Journal: Blood
Blood (2010) 116 (21): 439.
https://doi.org/10.1182/blood.V116.21.439.439
Published: 2010
Journal Articles

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, Sophie Grabar, Véronique Della-Valle, Françoise Picard, Franck Viguié, Bruno Quesnel, Odile Beyne-Rauzy, Eric Solary, Norbert Vey, Mathilde Hunault-Berger, Pierre Fenaux, Véronique Mansat-De Mas, Eric Delabesse, Philippe Guardiola, Catherine Lacombe, William Vainchenker, Claude Preudhomme, François Dreyfus, Olivier A. Bernard, Daniel Birnbaum, Michaëla Fontenay, on behalf of the Groupe Francophone des Myélodysplasies
Journal: Blood
Blood (2009) 114 (15): 3285–3291.
https://doi.org/10.1182/blood-2009-04-215814
Published: 2009
Includes: Supplemental data